STERISHEALTHCARE Products
Mumbai 08042755542 info@sterispharma.com
918209542042
Chat with us  

Chat with us on WhatsApp

×
Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
Home Products Coenzyme Q10 Tablets
COD not available
UROLOGYRANGE by CO ADD Q10 TABLET

Coenzyme Q10 Tablets

INR 74 INR 106
You Save: INR 32 (30.19%)
Check On
Share with
Check On
Share this on :

Description

Product details

Coenzyme Q10, commonly referred to as CoQ10, is a vital antioxidant naturally present in the human body. It plays a significant role in energy production and cellular protection. CO ADD Q10 Tablets, a high-quality formulation by Steris Healthcare, is designed to help maintain optimal CoQ10 levels in the body, supporting energy metabolism, cardiovascular health, and overall wellness. CoQ10 is particularly essential for individuals with low energy, aging-related oxidative stress, or those on statin medications, as these conditions can reduce the natural levels of CoQ10 in the body. CO ADD Q10 Tablets offer a convenient way to replenish this critical nutrient and promote a healthier, more active lifestyle. How CO ADD Q10 Tablet Works The primary function of CoQ10 is in the production of adenosine triphosphate (ATP), the energy currency of our cells. ATP is crucial for all bodily functions, including muscle contraction, nerve transmission, and organ performance. CO ADD Q10 enhances the efficiency of the mitochondria—the powerhouse of the cells—by participating in the electron transport chain, which is necessary for ATP generation. In addition to its role in energy production, CoQ10 acts as a potent antioxidant, neutralizing harmful free radicals that cause oxidative damage to cells and tissues. By reducing oxidative stress, CO ADD Q10 supports cardiovascular health, slows the aging process, and protects against chronic diseases. Composition Each CO ADD Q10 Tablet contains: Coenzyme Q10 (CoQ10) – 100 mg Excipients – q.s. This composition ensures a clinically effective dose of CoQ10, formulated for maximum absorption and bioavailability in the body. Uses of CO ADD Q10 Tablets CO ADD Q10 Tablets are recommended for a variety of health purposes: Supports Heart Health—CoQ10 strengthens cardiac muscle, supports normal blood pressure, and improves overall heart function. Enhances Energy Levels—By boosting ATP production, CO ADD Q10 reduces fatigue and increases stamina for daily activities. Powerful Antioxidant Protection – Protects cells from oxidative damage, promoting healthy aging and cellular wellness. Statin Support – Patients taking statin medications often have lower CoQ10 levels; supplementation helps restore these levels and reduce side effects like muscle pain. Overall Wellness – Supports immune function, mental clarity, and metabolic efficiency. Key Benefits of CO ADD Q10 Tablets Cardiovascular Health: Improves heart function and maintains healthy blood pressure levels. Energy & Stamina: Reduces fatigue and enhances physical and mental performance. Antioxidant Protection: Fights oxidative stress, protecting against cellular damage and age-related changes. Brain Function Support: CoQ10 contributes to neuroprotection, supporting focus, memory, and cognitive function. Supports Statin Therapy: Helps prevent statin-induced myopathy by replenishing depleted CoQ10 levels. Side Effects of CO ADD Q10 Tablets CO ADD Q10 Tablets are generally well-tolerated. However, some individuals may experience mild side effects, which are usually temporary. Common Side Effects Nausea or upset stomach Diarrhea or mild gastrointestinal discomfort Headache Dizziness Serious Side Effects (Rare) Allergic reactions such as rash, itching, or swelling Rapid heartbeat or palpitations in sensitive individuals If any severe symptoms occur, it is advised to discontinue use and consult a healthcare professional immediately. Dosage Guidelines For adults, the recommended dose is generally: 100 mg to 200 mg per day Take the tablet with meals to improve absorption Avoid taking on an empty stomach to reduce gastrointestinal discomfort Always consult a physician before starting CO ADD Q10 Tablets, especially if you are on medications or have underlying health conditions. Precautions & Warnings Consult a doctor before use during pregnancy or breastfeeding. Inform your healthcare provider if you are on blood thinners or heart medications. Store in a cool, dry place away from direct sunlight. Do not exceed the recommended dosage. Keep out of reach of children. Mechanism of Action Coenzyme Q10 functions as a cofactor in the mitochondrial electron transport chain, facilitating electron transfer from complex I and II to complex III, which is critical for ATP synthesis. By enhancing mitochondrial function, CO ADD Q10 improves energy production at the cellular level and reduces oxidative stress by neutralizing free radicals. This dual action—boosting energy and protecting cells—makes CO ADD Q10 an essential supplement for individuals seeking overall wellness and longevity. Clinical Evidence & Efficacy Scientific studies support the use of CoQ10 in various health areas: Improves cardiac output and ejection fraction in heart failure patients Reduces fatigue and enhances exercise performance Lowers oxidative stress markers, protecting against chronic diseases Supports patients on statin therapy by replenishing depleted CoQ10 levels These clinical findings validate CO ADD Q10 Tablets as a reliable choice for cardiovascular support, energy enhancement, and antioxidant protection. Frequently Asked Questions Q1. How long does it take to see benefits? A1. Noticeable improvements in energy and stamina can appear within 4–8 weeks of regular use. Q2. Can CO ADD Q10 Tablets be taken with other medications? A2. Generally yes, but consult a healthcare professional if you are taking blood thinners or heart medications. Q3. Are CO ADD Q10 Tablets suitable for elderly individuals? A3. Yes, they are safe for older adults and may help support energy levels and cardiovascular health. Q4. Can diabetics take CO ADD Q10 Tablets? A4. Yes, but consultation with a healthcare professional is recommended. Conclusion CO ADD Q10 Tablets by Steris Healthcare are a scientifically formulated Coenzyme Q10 supplement designed to support heart health, boost energy, and protect cells from oxidative damage. With its clinically validated composition, high absorption, and proven benefits, CO ADD Q10 is a trusted choice for anyone looking to maintain vitality and overall wellness. Whether you are seeking improved energy levels, cardiovascular support, or enhanced antioxidant protection, CO ADD Q10 Tablets provide a safe and effective solution for long-term health and well-being.

Other Specifications

Brand Name :CO ADD Q10
Manufactured By :Steris Healthcare Pvt Ltd
Package SIZE :10x1x15 Tablet
Storage :Store In A Cool & Dry Place
Country of origin :INDIA
  • Filter tags

Other Products

Related Products

LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short. ​ Product Description and Composition LINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk. ​ This unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically. ​ Mechanism of Action The triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake. ​ Synergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance. ​ Uses and Indications LINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy. ​ Prescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation. ​ Key Benefits LINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management: Superior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects. ​ Weight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect. ​ Cardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes. ​ Low Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas. ​ Convenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond. ​ Blood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg. ​ These benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs. Side Effects Common side effects mirror individual components but occur less due to synergy: Gastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly. ​ Genitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene. ​ Volume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics. ​ Serious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation. ​ Side Effect Category Frequency Management Nausea and Diarrhea Common (10%) Take with food, slow titration ​ UTI/Mycotic Infections Common (7%) Hydration, antifungals ​ Hypoglycemia Rare (<2%) With insulin, dose adjust ​ Lactic Acidosis Very Rare. Avoid in renal/hepatic failure ​ Ketoacidosis Rare (0.1%) Check ketones if nausea ​ Dosage and Administration Start with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity. ​ Missed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use. Precautions and Warnings Assess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated. ​ Drug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure. Frequently Asked Questions What is LINALIGIP EMPAMET used for? Controls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity. ​ Does it cause weight gain? No—it promotes 2-4 kg loss, unlike some antidiabetics. ​ Safe for kidneys? Renal-protective; monitor eGFR. ​ Hypoglycemia risk? Minimal without sulfonylureas. Conclusion LINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.
View Details
Empagliflozin,Linagliptin and Metformin Hydrochloride ER Tablets

INR220

FRUSIP 40 is a pharmaceutical formulation containing Frusemide IP 40mg as its active ingredient, presented in tablet form for oral administration. This medication belongs to the class of loop diuretics, which are among the most potent diuretic agents available in modern medicine. FRUSIP 40 is specifically designed to help manage conditions associated with fluid retention and elevated blood pressure, offering patients a reliable therapeutic solution for maintaining optimal fluid balance in the body. The formulation adheres to Indian Pharmacopoeia (IP) standards, ensuring consistent quality, purity, and efficacy. Each tablet is precisely manufactured to deliver the exact dosage required for effective treatment while maintaining the highest safety standards in pharmaceutical production. Understanding Furosemide and Its Mechanism Frusemide, also known as furosemide in some regions, is a powerful loop diuretic that works primarily in the kidneys. The medication exerts its therapeutic effect by inhibiting the reabsorption of sodium and chloride in the ascending loop of Henle, a specific segment of the kidney's nephron. This action prevents the body from retaining excess salt and water, leading to increased urine production and the subsequent elimination of accumulated fluids. The “loop” designation comes from the specific site of action within the kidney's loop of Henle, making frusemide significantly more potent than thiazide diuretics that work in different parts of the kidney. This enhanced potency makes FRUSIP 40 particularly valuable in managing conditions requiring substantial fluid removal. Primary Uses and Indications FRUSIP 40 is prescribed for various medical conditions where fluid accumulation poses health risks or causes discomfort: Edema Management: The medication is highly effective in treating edema (swelling) associated with congestive heart failure, where the heart's reduced pumping efficiency leads to fluid buildup in the lungs, legs, and other tissues. It helps alleviate breathing difficulties and reduces the strain on the cardiovascular system. Liver Disease: Patients with cirrhosis or other liver conditions often develop ascites, an accumulation of fluid in the abdominal cavity. FRUSIP 40 helps manage this uncomfortable and potentially dangerous condition by promoting fluid elimination. Kidney Disorders: In cases of nephrotic syndrome and other renal conditions causing fluid retention, this medication assists in maintaining proper fluid balance, though it must be used judiciously under medical supervision in patients with compromised kidney function. Hypertension Control: FRUSIP 40 serves as an effective antihypertensive agent, helping to lower blood pressure by reducing blood volume through increased fluid excretion. This is particularly beneficial for patients whose hypertension is resistant to other treatments. Pulmonary Edema: In acute situations where fluid accumulates in the lungs, this medication can provide rapid relief, making it a valuable tool in emergency medical settings. Key Benefits and Therapeutic Advantages The advantages of FRUSIP 40 extend beyond its primary diuretic function, offering patients multiple therapeutic benefits: Rapid Onset of Action: One of the most significant advantages is the quick response time. Patients typically experience diuretic effects within 30 to 60 minutes of oral administration, with peak effects occurring within one to two hours. This rapid action is particularly valuable in acute situations requiring prompt fluid removal. Potent Efficacy: As a loop diuretic, FRUSIP 40 demonstrates superior diuretic potency compared to thiazide diuretics, making it the preferred choice for patients with severe fluid retention or those who haven't responded adequately to milder diuretics. Cardiovascular Protection: By reducing fluid overload, the medication decreases the workload on the heart, helping to prevent complications in patients with heart failure. This protective effect can significantly improve quality of life and potentially reduce hospitalizations. Symptom Relief: Patients often experience notable improvement in symptoms such as shortness of breath, swelling in the extremities, and abdominal distension. This symptomatic relief contributes to enhanced mobility and daily functioning. Flexible Dosing: The 40mg strength allows healthcare providers to adjust treatment according to individual patient needs, either maintaining this dose or modifying it based on therapeutic response and tolerance. Electrolyte Management: When used under proper medical supervision with appropriate monitoring, the medication allows for controlled fluid management while maintaining awareness of electrolyte balance. Potential Side Effects and Considerations While FRUSIP 40 is generally well-tolerated, patients should be aware of potential side effects: Common Side Effects: These include increased urination frequency (which is expected), dizziness or lightheadedness upon standing (due to reduced blood volume), muscle cramps, and mild headaches. These effects often diminish as the body adjusts to the medication. Electrolyte Imbalances: The medication can cause depletion of important electrolytes, including potassium, sodium, magnesium, and calcium. Symptoms may include weakness, irregular heartbeat, confusion, or severe muscle cramps. Regular monitoring through blood tests is essential. Dehydration Risk: Excessive fluid loss can lead to dehydration, characterized by extreme thirst, dry mouth, decreased urine output, and confusion. Patients must maintain adequate fluid intake as directed by their healthcare provider. Metabolic Effects: Some patients may experience increased blood sugar levels, elevated uric acid (potentially triggering gout attacks), or changes in cholesterol levels. Hearing Changes: Rarely, particularly at higher doses, patients may experience ringing in the ears (tinnitus) or temporary hearing impairment. Photosensitivity: Increased sensitivity to sunlight may occur, requiring appropriate sun protection measures. Drug Interactions: FRUSIP 40 can interact with numerous medications, including certain antibiotics, other blood pressure medications, NSAIDs, and lithium, necessitating comprehensive medication review by healthcare providers. Important Safety Information Patients taking FRUSIP 40 should inform their healthcare provider about any existing medical conditions, particularly kidney disease, liver disease, diabetes, gout, or lupus. Pregnant and breastfeeding women require special consideration, as the medication crosses the placenta and appears in breast milk. Regular monitoring of kidney function, electrolyte levels, and blood pressure is essential for safe and effective therapy. Patients should maintain consistent communication with their healthcare team and report any unusual symptoms promptly. Conclusion FRUSIP 40 (Frusemide IP 40mg Tablets) represents a cornerstone therapy in the management of conditions involving fluid retention and hypertension. Its potent diuretic action, rapid onset, and proven efficacy make it an invaluable tool in cardiovascular and renal medicine. The medication offers significant benefits in symptom relief, cardiovascular protection, and overall quality of life improvement for patients struggling with edema and related conditions. However, the power of this medication demands respect and proper medical supervision. The potential for electrolyte imbalances and other side effects necessitates regular monitoring and open communication between patients and healthcare providers. When used appropriately under medical guidance, with proper monitoring and patient education, FRUSIP 40 can dramatically improve patient outcomes and help individuals regain control over conditions that significantly impact their daily lives. Patients prescribed FRUSIP 40 should view this medication as part of a comprehensive treatment plan that may include dietary modifications, lifestyle changes, and other medications. Success with this therapy depends on adherence to prescribed dosing, regular follow-up appointments, and proactive management of potential side effects. With proper use, FRUSIP 40 continues to serve as a trusted and effective therapeutic option for millions of patients worldwide requiring diuretic therapy.
View Details
Frusemide IP 40mg Tablets

INR14

MIRTAZPRIME 30 is a pharmaceutical formulation containing Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards. This prescription medication belongs to a class of drugs known as tetracyclic antidepressants and represents an advanced therapeutic option for individuals struggling with major depressive disorder and related mental health conditions. Manufactured under stringent quality control measures, MIRTAZPRIME 30 offers patients a reliable and effective solution for managing depression while also addressing associated symptoms such as insomnia and anxiety. Mirtazapine, the active pharmaceutical ingredient in MIRTAZPRIME 30, works through a unique dual mechanism that distinguishes it from other antidepressants. Unlike selective serotonin reuptake inhibitors (SSRIs), mirtazapine enhances the release of both norepinephrine and serotonin in the brain by blocking specific receptors. This innovative approach not only helps alleviate depressive symptoms but also provides sedative effects that can be particularly beneficial for patients experiencing sleep disturbances alongside depression. Therapeutic Uses and Applications MIRTAZPRIME 30 is primarily indicated for the treatment of major depressive disorder (MDD), a serious mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in daily activities. The medication has demonstrated significant efficacy in clinical trials, showing improvement in mood, energy levels, and overall quality of life for patients suffering from depression. Beyond its primary indication, healthcare providers may prescribe MIRTAZPRIME 30 for various off-label uses based on clinical judgment and patient needs. The medication has shown promise in managing generalized anxiety disorder, where excessive worry and tension interfere with daily functioning. Its sedative properties make it particularly valuable for patients experiencing insomnia related to depression or anxiety, as it can help restore healthy sleep patterns without the need for additional sleep medications. The 30mg dosage strength represents a therapeutic level commonly prescribed for maintenance treatment after initial dose titration. Patients typically begin with lower doses and gradually increase to 30mg as their body adjusts to the medication and their symptoms require more robust management. This dosage provides an optimal balance between therapeutic efficacy and side effect management for many individuals. MIRTAZPRIME 30 may also be considered for patients who have not responded adequately to other antidepressant therapies, offering an alternative mechanism of action that can break through treatment-resistant depression. Additionally, its appetite-stimulating effects can be beneficial for patients experiencing significant weight loss due to depression or other medical conditions. Key Benefits and Therapeutic Advantages The benefits of MIRTAZPRIME 30 extend beyond simple symptom relief, offering patients a multifaceted approach to mental health recovery. One of the most significant advantages is its relatively rapid onset of action compared to many other antidepressants. While most SSRIs require several weeks to demonstrate meaningful clinical improvement, patients taking mirtazapine often experience some relief from symptoms within one to two weeks, with continued improvement over subsequent weeks. The dual neurotransmitter action of MIRTAZPRIME 30 provides comprehensive coverage of depressive symptoms. By enhancing both serotonergic and noradrenergic neurotransmission, the medication addresses the complex neurochemical imbalances underlying depression more thoroughly than single-mechanism antidepressants. This broader action can result in more complete symptom resolution and better overall outcomes. Sleep improvement represents another crucial benefit of MIRTAZPRIME 30. The medication's sedative properties, particularly pronounced at lower doses, help patients fall asleep faster and enjoy more restorative sleep throughout the night. This is especially valuable since sleep disturbances are both a symptom and an exacerbating factor in depression. Better sleep quality contributes to improved daytime functioning, energy levels, and emotional regulation. Unlike many antidepressants that commonly cause sexual dysfunction, MIRTAZPRIME 30 has a relatively favorable profile in this regard. The medication is less likely to interfere with sexual function, making it an attractive option for patients who have experienced these troublesome side effects with other antidepressants. This characteristic can significantly improve treatment adherence and quality of life. The appetite-stimulating effect, while considered a side effect by some, can be therapeutically beneficial for patients experiencing significant weight loss or poor appetite due to depression. MIRTAZPRIME 30 can help restore healthy eating patterns and reverse the physical decline that often accompanies severe depressive episodes. Furthermore, MIRTAZPRIME 30 does not typically cause the gastrointestinal side effects commonly associated with SSRI antidepressants, such as nausea, diarrhea, or stomach upset. This improved gastrointestinal tolerability enhances patient comfort and compliance with treatment regimens. Potential Side Effects and Safety Considerations While MIRTAZPRIME 30 offers numerous therapeutic benefits, patients should be aware of potential side effects that may occur during treatment. Understanding these effects helps patients make informed decisions and enables early identification of any concerning symptoms requiring medical attention. The most commonly reported side effect is drowsiness or sedation, particularly during the initial weeks of treatment. This effect is typically most pronounced during the first few hours after taking the medication, which is why it's generally recommended for evening administration. Patients should exercise caution when driving, operating machinery, or engaging in activities requiring alertness until they understand how the medication affects them personally. Increased appetite and weight gain represent another frequent side effect of MIRTAZPRIME 30. While beneficial for some patients, others may find this effect undesirable. Weight gain typically ranges from moderate to significant and appears to be dose-related. Patients concerned about weight should discuss dietary strategies and exercise plans with their healthcare provider. Dry mouth is a common anticholinergic side effect that can cause discomfort but is generally manageable through increased fluid intake, sugar-free gum or candy, and good oral hygiene practices. Some patients may also experience dizziness, particularly when standing up quickly, due to the medication's effects on blood pressure regulation. Constipation may occur in some patients and can usually be managed through dietary modifications, increased fiber intake, adequate hydration, and regular physical activity. Less commonly, patients might experience confusion, abnormal dreams, or changes in thinking, particularly in older adults who may be more sensitive to the medication's effects. Serious side effects, while rare, require immediate medical attention. These include signs of allergic reactions such as rash, itching, swelling, severe dizziness, or difficulty breathing. Agranulocytosis, a dangerous decrease in white blood cells, is an extremely rare but serious complication that manifests as fever, sore throat, or signs of infection. Any unexplained fever or signs of infection should prompt immediate contact with a healthcare provider. Serotonin syndrome is another rare but potentially life-threatening condition that can occur when mirtazapine is combined with other medications affecting serotonin levels. Symptoms include agitation, hallucinations, rapid heartbeat, fever, excessive sweating, muscle stiffness, or coordination problems. Patients should inform their healthcare provider about all medications and supplements they are taking to avoid dangerous interactions. Abrupt discontinuation of MIRTAZPRIME 30 can lead to withdrawal symptoms, including nausea, anxiety, irritability, and flu-like symptoms. Therefore, any decision to stop the medication should be made in consultation with a healthcare provider who can develop an appropriate tapering schedule. Important Usage Guidelines MIRTAZPRIME 30 should always be taken exactly as prescribed by a qualified healthcare professional. The medication is typically administered once daily, preferably in the evening before bedtime due to its sedative effects. Tablets should be swallowed whole with water and can be taken with or without food, though taking them with food may help reduce any stomach upset. Consistency in timing is important for maintaining stable blood levels of the medication and optimizing therapeutic effects. Patients should try to take their dose at approximately the same time each evening. If a dose is missed, it should be taken as soon as remembered unless it's close to the time for the next scheduled dose, in which case the missed dose should be skipped rather than doubling up. The full therapeutic benefits of MIRTAZPRIME 30 may take several weeks to manifest. Patients should continue taking the medication as prescribed even if they don't feel immediate improvement. Premature discontinuation is a common reason for treatment failure in depression management. Regular follow-up appointments with the prescribing physician are essential for monitoring treatment response, adjusting dosages if necessary, and screening for potential side effects. Patients should maintain open communication with their healthcare team about their symptoms, concerns, and any changes in their condition. Conclusion MIRTAZPRIME 30 represents a valuable therapeutic option in the comprehensive management of major depressive disorder and related conditions. Its unique mechanism of action, combining enhanced noradrenergic and serotonergic neurotransmission with sedative and appetite-stimulating properties, offers distinct advantages for carefully selected patients. The medication's ability to improve both mood symptoms and sleep disturbances makes it particularly useful for patients experiencing depression accompanied by insomnia. The relatively favorable side effect profile, particularly regarding sexual function and gastrointestinal tolerability, enhances patient acceptance and adherence to treatment. While potential side effects such as sedation, increased appetite, and weight gain require monitoring and management, many patients find these effects tolerable compared to the debilitating symptoms of untreated depression. Success with MIRTAZPRIME 30, as with any antidepressant therapy, depends on proper patient selection, appropriate dosing, regular monitoring, and a comprehensive treatment approach that may include psychotherapy, lifestyle modifications, and social support alongside pharmacological intervention. Patients should work closely with their healthcare providers to optimize treatment outcomes and maintain long-term mental health wellness. The decision to use MIRTAZPRIME 30 should always be made collaboratively between patient and physician, considering individual symptoms, treatment history, coexisting medical conditions, and personal preferences. With proper use under medical supervision, MIRTAZPRIME 30 can be an effective tool in helping patients reclaim their lives from the devastating effects of depression and move toward recovery and renewed well-being.
View Details
Mirtazapine Tablet IP 30mg

INR262

Have any question or need any business consultation?

Contact Us

Have any question or need any business consultation?

Contact Us
Chat with us